Pierce R C, Rebec G V
Department of Psychology, Indiana University, Bloomington 47405.
J Neurosci. 1993 Oct;13(10):4272-80. doi: 10.1523/JNEUROSCI.13-10-04272.1993.
Behavioral findings suggest that the effects of neostriatal glutamate and ascorbate are opposed to those of neostriatal dopamine. Recent evidence also indicates that glutamate and ascorbate are linked via a carrier-mediated heteroexchange process, suggesting that ascorbate may act through the glutamate system to influence behavior. In order to assess glutamate-ascorbate interactions and their influence on the behavioral output of the basal ganglia, glutamate and homocysteic acid (a glutamate reuptake blocker) as well as NMDA antagonists were infused into the neostriatum of freely moving rats while extracellular neostriatal ascorbate was monitored via electrochemically modified carbon-fiber electrodes. Neostriatal 3,4-dihydroxyphenylacetic acid (DOPAC), a major dopamine metabolite, also was recorded in order to assess the dependency of any drug effect on the nigrostriatal dopamine system. Intraneostriatal infusions of L-glutamate (1 micrograms/microliters), but not L-homocysteic acid (30 micrograms/microliters), elevated extracellular neostriatal ascorbate levels. Neither of these drugs had any effect on neostriatal DOPAC or overt behavioral activity. Intraneostriatal infusion of the noncompetitive NMDA antagonist dizocilpine (MK-801; 3 micrograms/microliters) or the competitive NMDA antagonist 3-(2-carboxypiperazin-4-yl)-propyl-1-phosphonene (CPPene; 5 micrograms/microliters) decreased neostriatal ascorbate but had no effect on neostriatal DOPAC. Both dizocilpine and CPPene activated behavior in intact and sham-lesioned animals as well as in animals with near-total depletions of neostriatal dopamine following a 6-hydroxydopamine lesion. When administered systemically, however, dizocilpine (1.0 mg/kg) significantly increased neostriatal DOPAC. This effect appears to be regulated via midbrain NMDA receptors, in that this effect was completely abolished by electrolytic lesions of the substantia nigra pars reticulata.(ABSTRACT TRUNCATED AT 250 WORDS)
行为学研究结果表明,新纹状体谷氨酸和抗坏血酸的作用与新纹状体多巴胺的作用相反。最近的证据还表明,谷氨酸和抗坏血酸通过载体介导的异质交换过程相联系,这表明抗坏血酸可能通过谷氨酸系统来影响行为。为了评估谷氨酸 - 抗坏血酸的相互作用及其对基底神经节行为输出的影响,将谷氨酸和高半胱氨酸(一种谷氨酸再摄取阻滞剂)以及NMDA拮抗剂注入自由活动大鼠的新纹状体,同时通过电化学修饰的碳纤维电极监测细胞外新纹状体抗坏血酸水平。还记录了新纹状体主要多巴胺代谢产物3,4 - 二羟基苯乙酸(DOPAC),以评估任何药物效应是否依赖黑质纹状体多巴胺系统。向新纹状体内注射L - 谷氨酸(1微克/微升)可提高细胞外新纹状体抗坏血酸水平,但L - 高半胱氨酸(30微克/微升)则无此作用。这两种药物对新纹状体DOPAC或明显的行为活动均无影响。向新纹状体内注射非竞争性NMDA拮抗剂地佐环平(MK - 801;3微克/微升)或竞争性NMDA拮抗剂3 - (2 - 羧基哌嗪 - 4 - 基) - 丙基 - 1 - 膦烯(CPPene;5微克/微升)可降低新纹状体抗坏血酸水平,但对新纹状体DOPAC无影响。地佐环平和CPPene均可激活完整和假损伤动物以及6 - 羟基多巴胺损伤后新纹状体多巴胺几乎完全耗竭的动物的行为。然而,当全身给药时,地佐环平(1.0毫克/千克)可显著增加新纹状体DOPAC。这种效应似乎是通过中脑NMDA受体调节的,因为黑质网状部的电解损伤可完全消除这种效应。(摘要截短于250字)